Contents

  1. 2024: BSIR Venous Registry
  2. 2018: British Iliac Angioplasty and Stenting (BIAS) registry
  3. 2018: SIRT registry
  4. 2018: UK Rope Study
  5. 2013: BSIR Inferior Vena Cava filter registry

2024: BSIR Venous Registry

 

The BSIR Venous Registry was a clinical audit used to evaluate the safety and effectiveness of treatments for DVT. It was established to improve the care of people with acute iliofemoral DVT (blood clot within the veins of the pelvis or upper leg) and chronic iliofemoral venous obstruction (blocked veins as a long-term complication of these blood clots).

While the registry was open, the National Institute for Health and Care Excellence (NICE), the organisation that provides national guidance and advice to improve health and social care, recommended that doctors performing treatments for these conditions enter relevant information on this Registry.

This Registry was accessible to all clinicians (Interventional Radiologists, Vascular Surgeons and Haematologists) managing patients with acute iliofemoral DVT and aimed to collect standardised data on all patients referred for consideration of percutaneous mechanical thrombectomy/thrombolysis in the UK. Furthermore, this Registry collected data on patients undergoing percutaneous image-guided interventions in symptomatic chronic post-thrombotic and non-thrombotic iliofemoral venous outflow obstruction.

Results from this survey will be made available.

Back to top


2018: British Iliac Angioplasty and Stenting (BIAS) registry

The BSIR is very proud to have instigated and supported the British Iliac Angioplasty and Stenting (BIAS) registry. BIAS was one of the vanguard registries in the United Kingdom. This report joins its three predecessors, and is not only useful for its content, but is also a tribute to all those BSIR members who have taken the time to complete data entry. 

BIAS is (to the best of The Society’s knowledge) the largest iliac artery endovascular intervention registry worldwide, with over 13,000 patients entered over its 16 years of operation. It demonstrated the commitment of the British Interventional Radiology community to ensuring that this index procedure for vascular interventional radiology is delivered safely and is benchmarked for future delivery. We can see that patients experience good outcomes at follow up, which is key. BIAS also provided excellent longitudinal information about the way services are delivered, for example the ever-increasing use of day-case facilities.

The BSIR BIAS registry of iliac intervention was closed to data collection in 2016 after the expansion of the NVR to include peripheral intervention cases. In total 117 centres have contributed to BIAS since its inception in 2000.

This is the final report from BIAS summarising data on 8294 procedures reported to the registry between 2011 and 2014 inclusive. At peak data entry (2013) nearly 50 patients per week were reported.

You can read the fourth, and final, report here:

BIAS Report - Fourth Iliac Angioplasty Study Report - February 2018

Back to top


2018: SIRT registry

Working in partnership, BSIR supported the implementation of a national registry for Selective Internal Radiation Therapy for Colorectal Cancer Liver Metastases.

Purpose

The purpose of the UK Registry is to build a database of patient demographics, primary and secondary diagnoses, treatment details, treatment effects and adverse events in order to evaluate and analyse patient outcomes from SIRT therapy.

Method

Patients eligible for treatment had histologically con rmed carcinoma with liver-only/liver-dominant metastases with clinical progression during or following oxaliplatin-based and irinotecan-based chemotherapy. All patients received SIRT plus standard of care. The primary outcome was overall survival; secondary outcomes included safety, progression-free survival (PFS) and liver-specific PFS (LPFS).

Analysis of this National Programme for Selective Internal Radiation Therapy for Colorectal Cancer Liver Metastases was published in 2018, which can be accessed below.

Back to top


2018: UK Rope Study

As a joint initiative between the British Society of Interventional Radiologists, the British Association of Urological Surgeons and the National Institute for Health and Care Excellence, we conducted the UK Register of Prostate Embolization (UK-ROPE) study. 

Purpose

To assess the efficacy and safety of prostate artery embolization (PAE) for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and to conduct an indirect comparison of PAE with transurethral resection of the prostate (TURP).

Method

The UK Register of Prostate Embolization (UK-ROPE) study recruited 305 patients across 17 UK urological/interventional radiology centres, 216 of whom underwent PAE and 89 of whom underwent TURP. 

Analysis of the study was published in April 2018, and the results can be found here:

https://onlinelibrary.wiley.com/doi/abs/10.1111/bju.14249

Back to top


2013: BSIR Inferior Vena Cava filter registry

Purpose

The British Society of Interventional Radiology (BSIR) Inferior Vena Cava (IVC) Filter Registry was produced to provide an audit of current United Kingdom (UK) practice regarding placement and retrieval of IVC filters to address concerns regarding their safety.

Methods

The IVC filter registry was a web-based registry, launched by the BSIR on behalf of its membership in October 2007. The summary report, published in 2013, was based on prospectively collected data from October 2007 to March 2011. This report contains analysis of data on 1,434 IVC filter placements and 400 attempted retrievals performed at 68 UK centers. Data collected included patient demographics, insertion and retrieval data, and patient follow-up.

Publication of findings are here:

https://link.springer.com/article/10.1007/s00270-013-0606-2

https://link.springer.com/content/pdf/10.1007/s00270-013-0606-2.pdf

Back to top